Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation ProteinThomas Lindner, Uwe Haberkorn|Journal of Nuclear Medicine|2018Cited by 908
Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemcitabine.Uwe Haberkorn, G. van Kaick, Iris Morr et al.|PubMed|1994Cited by 63
Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic reviewPaul Windisch, Sebastian Adeberg, Daniel R. Zwahlen et al.|EJNMMI Research|2021Cited by 51
Oral Delivery of the Vancomycin Derivative FU002 by a Surface‐Modified Liposomal NanocarrierJulia Werner, Philipp Uhl, Walter Mier et al.|Advanced Healthcare Materials|2024Cited by 28
Fatty Acid Conjugation Leads to Length-Dependent Antimicrobial Activity of a Synthetic Antibacterial Peptide (Pep19-4LF)Philip Storck, Philipp Uhl, Florian Umstätter et al.|Antibiotics|2020Cited by 23